Skip to main content
Caplight Logo









EicOsis Human Health, Inc.

EicOsis Human Health, Inc.

Private
Davis, CaliforniaHealthcare & Life Scienceshttps://www.eicosis.com/

Last Round

Grant

Jan 1, 2025

Total Funding Raised

$21.27M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

EicOsis Human Health, Inc. is a biopharmaceutical company developing non-narcotic oral analgesics that inhibit the soluble epoxide hydrolase (sEH) enzyme to treat neuropathic and inflammatory pain.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

biopharmaceuticalsmall molecule inhibitorsoluble epoxide hydrolasesEHneuropathic painnon-narcotic pain reliefdrug discoveryclinical trialsnon-opioid pain managementbiotechinflammatory diseasepain therapeuticsdrug developmentclinical-stage biotechpainkiller alternatives

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

EicOsis Human Health, Inc. Comparables

Compare EicOsis Human Health, Inc. with similar companies based on industry and business-model similarity.

EicOsis Human Health, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
South Rampart Pharma, Inc.
82%
Algiax Pharmaceuticals
80%
Regulonix
79%

EicOsis Human Health, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 1, 2025
GrantOct 30, 2019
GrantOct 15, 2019
VC RoundMar 19, 2019
GrantJan 8, 2016

EicOsis Human Health, Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors increased 118% MoM.

  • Jun 1, 2025

    Monthly visitors increased 101% MoM, reaching 600.

EicOsis Human Health, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

EicOsis Human Health, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about EicOsis Human Health, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersDavis, California
Employee Range8
Year Founded2011
Last FundingJan 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?